期刊名称：JOURNAL OF PATHOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The main interests of The Journal of Pathology lie in the pathophysiological and pathogenetic mechanisms of human disease and in the application of such knowledge to diagnosis and prognosis. In determining content, the primary considerations are excellence, relevance and novelty.
The Journal welcomes investigative studies on human tissues, experimental studies in vitro and in vivo, and investigations based on animal models with a clear relevance to human disease, including transgenic systems. Methodological improvements in investigative and diagnostic pathology are also of interest. Correlative studies of pathological data and clinical outcomes are encouraged, but purely descriptive papers on diagnostic pathology are not considered central to the Journal's purpose. In general, studies that appropriately employ multiple investigative techniques are preferred over those that rely on a single methodology. Illustrations must be of the highest quality to be acceptable for publication. As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles and other features, both contributed and solicited. Papers covering significant developments in teaching methods and in the practice of pathology may be acceptable, if they are of international scope and relevance. Correspondence from readers will be published if it is of general interest.
In summary, the Journal aims to serve as a bridge between basic biomedical science and clinical medicine with particular emphasis on morphologically based studies. As the journal of the Pathological Society of Great Britain and Ireland, it seeks to reflect the broad scientific interests of the Society's membership, but its ethos, authorship, content and purpose are those expected of a leading publication in the international scientific literature.
|
Instructions to Authors
The Review Process
The Editor-in-Chief assigns manuscripts to Associate Editors. The Associate Editor solicits reviewers (typically, two external reviews are sought). The reviewer evaluations and Associate Editor's comments are compiled by the Editor-in-Chief for disposition and transmittal to the authors. This is usually within six weeks of the receipt of the manuscript.
Authors may provide the Editor-in-Chief with the names, addresses and email addresses of up to three suitably qualified individuals of international standing who would be competent to referee the work, although the Editor-in-Chief will not be bound by any such nomination. Likewise, authors may advise of any individual who for any reason, such as potential conflict of interest, might be inappropriate to act as a referee, again without binding the Editor-in-Chief.
The Editor-in-Chief will advise authors whether a manuscript is accepted, should be revised, should be resubmitted or is rejected. Revised manuscripts must be sent back to the Journal within 8 weeks of notification, otherwise, other than in exceptional circumstances, they will be treated as a new submission. Resubmitted manuscripts will be considered as new submissions.
A number of manuscripts considered suitable for publication will have to be rejected on the grounds of priority and available space. A manuscript may be returned to the authors without outside review if the Editor-in-Chief and Associate Editors find it inappropriate for publication in this Journal. Similarly, the Editors may expedite the review process for manuscripts felt to be of high priority in order to reach a rapid decision. This 'fast-track decision' will normally occur within one week of receipt of the manuscript.
Issues to consider
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor-in-Chief about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. Investigators should disclose potential conflicts to study participants and should state in the manuscript whether they have done so. Authors should describe the role of the study sponsor(s), if any, in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the report for publication. If the supporting source had no such involvement, the authors should so state.
Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
Research reports frequently omit important information. Authors are encouraged in addition to consult reporting guidelines relevant to their specific research design. For reports of randomised controlled trials authors should refer to the CONSORT statement.
Manuscript Requirements
Summary of Technical Requirements
- Double space all parts of the manuscript.
- Begin each section or component on a new page.
- Review the sequence: title page, declaration page, abstract and key words, text, acknowledgements, references, tables (each on separate page), legends.
- Illustrations should be no larger than 203 ?254 mm (8 ?10 inches).
- Include permission to reproduce previously published material in all media forms (not just print) or to use illustrations that may identify patients.
- Include copies of all papers cited as 'in press'.
- Keep copies of everything submitted.
Preparation of Manuscript
The text of observational and experimental articles is divided into sections with the headings Introduction, Methods, Results and Discussion. Long articles may need subheadings within some sections (especially the Results and Discussion sections) to clarify their content. Other types of articles, such as reviews and editorials, still need a title and should adhere as closely as possible to the guidelines.
Type or print out the manuscript on white bond paper, US Letter (8.5 ?11 inches) or A4 (210 ?297 mm), with margins of at least 25 mm. Type or print on only one side of the paper. Use double spacing throughout, including for the title page, abstract, text, acknowledgements, references, individual tables and legends. Number pages consecutively, beginning with the title page. Put the page number in the upper or lower right-hand corner of each page. Figures and tables must be supplied on a separate page for each and not embedded into the manuscript's text.
Manuscripts on Disk
When submitting disks, authors should:
- Include three print-outs of the version of the article that is on the disk.
- Put only the latest version of the manuscript on the disk.
- Name the file clearly.
- Label the disk with the format of the file and the file name
- Provide information on the software used.
We accept only PC-formatted 3.5-inch floppy or Zip disks, or CD-Roms, using preferably Microsoft Word as the software package for the text.
Illustrations must be submitted in electronic format where possible. Save each figure as a separate file, in TIFF or EPS format preferably. Write on the disk the software package used to create them; we favour dedicated illustration packages over tools such as Excel or Powerpoint.
Title Page
The title page should carry 1) the full title and a suggested short title of the article; 2) the name by which each author is known and institutional affiliation; 3) the name of the department(s) and institution(s) to which the work should be attributed; 4) disclaimers, if any; 5) source(s) of support in the form of grants, equipment, drugs or all of these; 6) an accurate word count of the text from the start of the introduction to the end of the discussion.
Authorship
All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article.
Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.
Declaration
The second page must include 1) information on prior or duplicate publication or submission elsewhere of any part of the work as defined earlier in this document; 2) a statement of financial or other relationships that might lead to a conflict of interest as defined earlier in this document; 3) a statement that the manuscript has been read and approved by all the authors, that the requirements for authorship have been met and that each author believes that the manuscript represents honest work; 4) the name, address, telephone and fax numbers, and email address of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs.
Abstract
The third page should carry an abstract of up to 300 words. The abstract should state the purposes of the study or investigation, the basic procedures, the main findings and the principal conclusions. It should emphasise new and important aspects of the study or observations. It should be understandable without reference to the rest of the paper and should contain no citation to other published work.
Key Words
Below the abstract authors should provide and identify as such three to 10 key words or short phrases to assist indexing the article and may be published with the abstract.
Main Text
There are approximately 900 words on a full printed page of journal text. Full articles should not exceed 3000 words which is approximately six journal pages, including tables, figures and references. Short articles should not exceed four journal pages, including tables, figures and references. Review articles and special features may exceed these limits by arrangement with the Editor-in-Chief. Succinct articles are likely to make a greater impact on readers than long ones and are more likely to be accepted for publication without delay.
Introduction
State the purpose of the article and summarise the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.
Methods
Describe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex and other important characteristics of the subjects. As the relevance of such variables as age, sex and ethnicity to the object of research is not always clear, authors should explicitly justify them when they are included in a study report. The guiding principle should be clarity about how and why a study was performed in a particular way. Authors should avoid terms such as 'race' which lacks precise biological meaning and use alternative descriptors such as 'ethnicity' or 'ethnic group' instead. Authors should specify carefully what the descriptors mean and tell exactly how the data were collected.
Identify the methods, apparatus (give the manufacturer's name and address in parentheses) and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s) and route(s) of administration.
Reports of randomised clinical trials should present information on all major study elements, including the protocol (study population, interventions or exposures, outcomes and the rationale for statistical analysis), assignment of interventions (methods of randomisation, concealment of allocation to treatment groups) and the method of masking (blinding).
Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting and synthesising data. These methods should also be summarised in the abstract.
Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed.
Statistics
Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). References for the design of the study and statistical methods should be to standard works when possible (with pages stated) rather than to papers in which the designs or methods were originally reported.
Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a randomising device), 'normal', 'significant', 'correlations' and 'sample'.
Results
Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasise or summarise only important observations.
Discussion
Emphasise the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. Include in the Discussion section the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies.
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by the data. In particular, authors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted but clearly label them as such. Recommendations, when appropriate, may be included.
Acknowledgements
List all contributors who do not meet the criteria for authorship, such as a person who provided purely technical help, writing assistance or a department chair who provided only general support. Financial and material support should also be acknowledged.
Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as 'clinical investigators' or 'participating investigators' and their function or contribution should be described.
References
References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals in square parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. All references should be complete and accurate.
Use the style of the examples below (full Vancouver), which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Consult the List of Journals Indexed in Index Medicus. The list can also be obtained through the library's web site (http://www.nlm.nih.gov).
Avoid using abstracts as references. References to papers accepted but not yet published should be designated as 'in press'; authors should obtain written permission to cite such papers as well as verification that they have been accepted for publication. Copies of any papers cited as 'in press' must be included in the submission. Avoid using unpublished observations and information from manuscripts submitted but not accepted
Avoid citing a 'personal communication' unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. Authors must supply written permission and confirmation of accuracy from the source of a personal communication.
- Koreth J, Bakkenist CJ, McGee JO'D. Chromosomes, 11q and cancer: a review. J Pathol 1999;187:28-38.
- Desmet VJ, Caller F. Cholestatic syndromes of infancy and childhood. In Hepatology: a Text Book of Liver Disease, Zakim D, Boyer TD (eds), vol 2. W.B. Saunders: Philadelphia, 1990;1355-1395.
- Sadler TW. Langman's Medical Embryology (5th edn). Williams & Wilkins: Baltimore, 1985;224-226.
Tables
Type each table with double spacing on a separate page. Do not submit tables as photographs. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations, such as standard deviation and standard error of the mean. Do not use internal horizontal and vertical rules. Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge fully.
Illustrations (Figures)
Figures should be numbered consecutively according to the order in which they have been first cited in the text. If a figure has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. Permission is required irrespective of authorship or publisher except for documents in the public domain.
If photographs of people are used, either the subjects must not be identifiable or their pictures must be accompanied by written permission to use the photograph (see Issues to Consider).
Symbols, arrows or letters used in photomicrographs should contrast with the background.
For on-line submission, see the guidelines for authors on how to submit on the website (http://jpath-wiley.manuscriptcentral.com). Otherwise, submit three complete sets of figures. Figures should be professionally drawn and photographed; freehand or typewritten lettering is unacceptable. Instead of original drawings, X-ray films, transparencies and other material, send sharp, glossy, black-and-white or colour photographic prints, usually 127 ?173 mm (5 ?7 inches) but no larger than 203 ?254 mm (8 ?10 inches). Letters, numbers and symbols should be clear and even throughout and of sufficient size that when reduced for publication each item will still be legible. Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.
Each figure should have a label pasted on its back indicating the number of the figure, author's name and top of the figure. Do not write on the back of figures or scratch or mar them by using paper clips. Do not bend figures or mount them on cardboard.
Legends for Illustrations
Type legends for illustrations using double spacing, starting on a separate page, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Do not indicate the magnification for light micrographs. Internal scale markers are recommended for electron micrographs. Indicate the type of stain used only if it is other than haematoxylin and eosin.
Units of Measurement
Measurements of length, height, weight and volume should be reported in metric units (metre, kilogram or litre) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimetres of mercury. All haematological and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI).
Abbreviations and Symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Copyright
To enable the publisher to disseminate the author's work to the fullest extent, the author must sign a Copyright Transfer Agreement, transferring copyright in the article from the author to the publisher, and submit the original signed agreement with the article presented for publication for hard copy submission (For on-line submission, agreements will be requested once a paper has been accepted for publication.) A copy of the agreement to be used (which may be photocopied) can be found in the first issue of each volume of The Journal of Pathology. Copies may also be obtained from the editorial office, from the journal website or the on-line submission website.
Sending the Manuscript
There are two options:
1) The Journal of Pathology operates an on-line submission system. Details of how to submit on-line, copyright forms and full author instructions can be found at http://jpath-wiley.manuscriptcentral.com. Referees may ask to see hard copies of electronic figures for clarification; these must be available immediately on request.
2) Alternatively, send three copies of the printed manuscript, tables and illustrations in a heavy-paper envelope, enclosing the copies and figures in cardboard, if necessary, to prevent the photographs from being bent. Place photographs in a separate heavy-paper envelope. Send also an electronic copy of the text and, where possible, the illustrations, on disk. Place the disk in a separate heavy-paper envelope. Enclose each envelope in one parcel for mailing. All hard copy submissions will be entered into the on-line database and may be tracked by the author. An explanatory email will be sent to the corresponding author.
Submit the manuscript to the Managing Editor, The Journal of Pathology, Pathological Society of Great Britain and Ireland, 2 Carlton House Terrace, London SW1Y 5AF, UK. Tel: +44 (0)20 7930 4315. Fax: +44 (0)20 7976 1267. The e-mail address for the Editorial Office is managing_editor@jpathol.org. This email address is for correspondence and not for the submission of manuscripts.
Further Information
Once a manuscript has been accepted for publication, the Editor-in-Chief must receive a Copyright Transfer Agreement with original signatures and a letter signed by all co-authors stating that the final version of the manuscript for publication has been read and approved by all the authors. High-resolution electronic images and/or hard copies of figures will be requested if they have not already been received.
Proofs will be sent to the author for checking. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of the paper being held over to a later issue.
There is no page charge to authors. The cost of printing colour illustrations in the journal is currently ?00 per colour page and will be charged to the author. These may be submitted as high-resolution electronic images or prints. In exceptional circumstances, if colour reproduction is considered essential by the referees and if the authors and their institutions or funding agencies are unable to meet the full cost, publication of colour may be made available at a reduced rate. The funds available for this purpose are limited and will be employed at the discretion of the Editor-in-Chief. Authors wishing to seek this subsidy should explain the circumstance to the Editor-in-Chief on submission of the manuscript.
Twenty-five complimentary offprints of papers will be provided to the author who checked the proofs, unless otherwise indicated. Further offprints and copies of the journal may be ordered.
EarlyView
EarlyView is Wiley's exclusive service presenting individual articles online as soon as they are ready before the release of the compiled print issue. EarlyView articles are complete and citable and are published in an average time of six weeks from acceptance.
Disclaimer
The validity of the data and the views expressed in articles in the journal are the responsibility of authors and not of the Pathological Society of Great Britain and Ireland or the publisher, John Wiley & Sons, Ltd.
Editorial Board
| EDITOR-IN-CHIEF |
Professor C Simon Herrington
Bute Medical School, Bute Medical Building, University of St Andrews, St Andrews, Fife KY16 9TS, UK
|
ASSOCIATE EDITORS |
Professor Fred T Bosman
University Institute of Pathology, Rue de Bugnon 25, 1011 Lausanne, Switzerland |
Professor Peter A Hall
Pathology & Cancer Research Centre, Queen's University of Belfast, Royal Hospitals Trust, Grosvenor Road, Belfast BT12 6BL, UK |
Professor Andrew M Hanby
Department of Histopathology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK |
Professor C James Kirkpatrick
Institute of Pathology, Johannes Gutenberg University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany |
Professor Richard Poulsom
Histopathology Unit, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK |
Professor Rosemary A Walker
Department of Pathology, Clinical Sciences Building, PO Box 65, Leicester Royal Infirmary, Leicester LE2 7LX, UK |
ADVISORY BOARD |
Professor CDM Fletcher
Boston, USA |
Professor PG Isaacson
London, UK |
Professor JR Jass
Montreal, Canada |
Professor G Kloppel
Kiel, Germany |
Professor CJLM Meijer
Amsterdam, The Netherlands |
Professor M Pignatelli
Bristol, UK |
Professor M Sobrinho-Simoes
Porto, Portugal |
Professor H Stein
Berlin, Germany |
Professor PG Toner
Cheltenham, UK |
Professor DH Wright
Winchester, UK |
Professor NA Wright
London, UK |
Professor AH Wyllie
Cambridge, UK |
Professor RM Zinkernagel
Zurich, Switzerland |
EDITORIAL BOARD |
Professor M Alison
London, UK |
Dr MJ Arends
Cambridge, UK |
Professor J Bartek
Copenhagen, Denmark |
Professor P Bedossa
Le Kremlin Bicetre, France |
Dr PJ Coates
Dundee, UK |
Professor C Cuvelier
Ghent, Belgium |
Professor MJAP Daemen
Maastricht, The Netherlands |
Dr DC Douek
Bethesda, USA |
Professor S Fleming
Dundee, UK |
Professor AJ Freemont
Manchester, UK |
Professor P Furness
Leicester, UK |
Dr P Harnden
Leeds, UK |
Professor KJ Hillan
San Francisco, USA |
Professor F Hofstadter
Regensburg, Germany |
Professor PCW Hogendoorn
Leiden, The Netherlands |
Dr M Ilyas
Oxford, UK |
Professor D Jenkins
Nottingham, UK |
Professor SR Lakhani
London, UK |
Professor JE Martin
London, UK |
Professor U Moll
Stony Brook, USA |
Professor S Mori
Tokyo, Japan |
Dr GI Murray
Aberdeen, UK |
Professor G Niedobitek
Erlangen, Germany |
Professor ST Pals
Amsterdam, The Netherlands |
Professor MG Papotti
Turin, Italy |
Dr SEH Russell
Belfast, Northern Ireland |
Professor W Timens
Groningen, The Netherlands |
Dr IPM Tomlinson
London, UK |
|
刊名字顺( Alphabetical List of Journals):
返回页首 